Skip to main content

Stryker Hip-Implant Plaintiffs Prepping Up

Stryker Hip-Implant Plaintiffs Prepping Up

Stryker Hip-Implant Plaintiffs Prepping Up

Introduction

From the Stryker Hip-Implant lawsuit comes the news that 3 plaintiffs had put forth a motion to remand three claims to the Massachusetts state court. All three claims were against Surgi-Care, a Massachusetts distributor of the Stryker hip components, wherein the plaintiffs suffered hip replacement complications following implantation of Stryker's Accolade TMZF Hip Stem and LFIT Anatomic V40 Femoral Head. The manufacturer, however, argued that since Surgi-care had no power to make any changes to the design, labeling, or packaging of the LFIT V40 Femoral Heads, the plaintiffs were barred from pursuing claims against Surgi-Care; hence, it could be removed on a pre-emption basis. The plaintiffs, on the other hand, are confident that the defendant's theory for removal is baseless and does not apply to lawsuits that involve devices cleared via the FDA's 510(k) program, which was the case with LFIT V40 Femoral Heads.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!